US FDA Outlines Format For Race, Ethnicity Data Collection
Executive Summary
The guidance document tells sponsors to ask about ethnicity before race, and provides suggested wording. It updates a 2005 guidance.
You may also be interested in...
FDA Details Preferred Approach To Collecting Diversity Data
In a recent guidance document, the FDA explains how trial sponsors should collect and present data on the race and ethnicity of trial participants.
US FDA Draft Guidance Tells Medtech How To Recruit, Report Trial Subpopulations
Medical device makers should be prepared to identify and consider specific differences between patients of varying ages, races and ethnicities, and incorporate queries about subgroups into clinical trial designs and reports supporting 510(k) and premarket approval (PMA) submissions, the US Food and Drug Administration says in a guidance 1,2.
‘Core Pillars’ Of Safety And Innovation Take Center Stage In FDA Reports
The US FDA has issued a pair of reports focused on device safety and innovation. The reports describe recent steps the agency has taken to improve in the two areas, and what it plans to do next.